What's new 

Formulary Group Decisions May 2010

• Febuxostat tablets (Adenuric®) 
• Fondaparinux sodium, 2.5mg/0.5mL solution for injection, pre-filled syringe (Arixtra®) 
• Histrelin acetate, 50mg subcutaneous implant (Vantas®) 
• Lenalidomide capsules (Revlimid®) 
• Raltegravir tablet (Isentress®)
• Tobramycin 300mg/4mL nebuliser solution (Bramitob®)
• Ustekinumab injection (Stelara®)